(Q43239620)

English

Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial

scientific article published in October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

amyotrophic lateral sclerosis

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Vincent Meininger

1

object named as

Vincent Meininger

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Albert C. Ludolph

4

object named as

Albert Ludolph

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

5

object named as

Wim Robberecht

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

3

object named as

P Nigel Leigh

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

author name string

Vivian E Drory

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Vincenzo Silani

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

1 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

378-383

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Unraveling the mechanisms involved in motor neuron degeneration in ALS

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

ALS: a disease of motor neurons and their nonneuronal neighbors

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention.

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Controlled autoimmunity in CNS maintenance and repair: naturally occurring CD4+CD25+ regulatory T-Cells at the crossroads of health and disease

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

T cells in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Neurogenesis and neuroprotection in the CNS--fundamental elements in the effect of Glatiramer acetate on treatment of autoimmune neurological disorders

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop.

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Therapy development for ALS: lessons learned and path forward

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Learning from failed trials in ALS.

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Minocycline for patients with ALS.

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Phase II/III randomized trial of TCH346 in patients with ALS

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Onset and progression in inherited ALS determined by motor neurons and microglia

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS).

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Design of phase II ALS clinical trials.

1 reference

https://api.crossref.org/works/10.3109%2F17482960902803432

21 January 2018

Identifiers

10.3109/17482960902803432

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43239620&oldid=1984690856"